1. Is Camson Bio Technologies Ltd. a good quality company?
Data is not available for this company.
2. Is Camson Bio Technologies Ltd. undervalued or overvalued?
The key valuation ratios of Camson Bio Technologies Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.
3. Is Camson Bio Technologies Ltd. a good buy now?
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Camson Bio Technologies Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
Value Creation ⓘ
Value Creation Index Colour Code Guide ⓘ
|ROCE % ⓘ||23.5%||24%||17.1%||14.4%||7.9%||2.1%||-15.2%||-13.6%||-6.3%||-20.1%||-|
|Value Creation Index ⓘ||0.7||0.7||0.2||0.0||-0.4||-0.9||-2.1||-2.0||-1.5||-2.4||-|
Growth Parameters ⓘ
Growth Parameters Colour Code Guide ⓘ
|YoY Gr. Rt. %||-||23.5%||13.7%||6.6%||21.8%||16.3%||-85%||-59.3%||86.6%||-74.2%||-|
|Adj EPS ⓘ||8.5||12.1||11.4||12.7||6.3||1||-12.6||-7.7||-3.7||-7.3||-8.4|
|YoY Gr. Rt. %||-||42.7%||-5.9%||11%||-50.8%||-83.7%||-1336.3%||NA||NA||NA||-|
|BVPS (₹) ⓘ||43.2||57.9||69.3||80.8||80.8||88||34.8||25.7||22.2||14.9||12.4|
|Adj Net Profit ⓘ||13.7||22||20.7||23||15.8||3.1||-37.8||-23.2||-11.2||-21.9||-25|
|Cash Flow from Ops. ⓘ||10.5||-1.9||10.2||-13.5||-14.7||14.1||-10||4.6||1.8||0||-|
|Debt/CF from Ops. ⓘ||0.1||-0.6||1.2||-3||-2.7||2.6||-4.7||10.1||26.7||554260.7||-|
CAGR Colour Code Guide ⓘ
|9 Years||5 Years||3 Years||1 Years|
|Adj EPS ⓘ||-198.3%||-203.2%||NA||NA|
Key Financial Parameters ⓘ
Performance Ratio Colour Code Guide ⓘ
|Return on Equity % ⓘ||23.7||24.1||17.8||16||8.1||1.3||-20.5||-25.6||-15.6||-39.3||-61.4|
|Op. Profit Mgn % ⓘ||20.3||22.8||19.6||23.6||17||10.9||-56.6||-127.7||0.2||-329.4||-439.3|
|Net Profit Mgn % ⓘ||17.1||22.3||18.5||19.2||10.8||1.8||-148.9||-224.1||-58.2||-440||-516.8|
|Debt to Equity ⓘ||0||0||0.1||0.3||0.2||0.1||0.5||0.6||0.7||1.1||-|
|Working Cap Days ⓘ||142||226||297||354||385||382||1,745||1,871||899||3,057||0|
|Cash Conv. Cycle ⓘ||125||188||237||270||275||299||1,356||606||483||2,737||0|
No data to display
Return on Equity has declined versus last 3 years average to %
Sales growth has been subdued in last 3 years %
Sales growth is not so good in last 4 quarters at %
|TTM EPS (₹)||-8.4||-3.7|
|TTM Sales (₹ Cr.)||4.9||19.3|
|BVPS (₹.) ⓘ||12.4||0|
|Reserves (₹ Cr.) ⓘ||7||37|
|From the Market|
|52 Week Low / High (₹)||3.31 / 3.31|
|All Time Low / High (₹)||3.31 / 252.00|
|Market Cap (₹ Cr.)||9.9|
|Equity (₹ Cr.)||30|
|Face Value (₹)||10|
|Industry PE ⓘ||18.3|
Camson, incorporated in 1993 is India's first wholly integrated Agriculture Biotechnology, is based at Bangalore, garden city of India. It became a Public Company in 1995. Camson has been promoted by technocrats with vast relevant experience. Its Vision is to create a healthy and disease free society by providing safe food. This vision forms the guiding beacon of Camson in its pursuit for wholesome goodness in agriculture and aims at being world class manufacture of Biotechnology products
The Company has a strong presence in the Indian market and has unique research and intellectual proprietary which gives the Company an edge over others. Its proprietary technology platform consists of microorganism database, superior proprietary seeds germplasm, screening technology, biocides, biofertilisers and hybrid seeds.
Camson has developed many unique biocides for plant protection and hybrid seeds for improved productivity. Their superior technology in crop transformation and functional genomics has helped in developing new products which are first of its kind in the country.
The infrastructure set up of the Company is at Bangalore North. The set up provides for a total composite production. It is State-of-the-art and spread over 20 acres of land. This affords a high level of space for multi-product production, simultaneously. The Company constantly upgrades its production facilities to keep pace with the increased demand for its products as also for producing a wider range of products pursuant to the success achieved on its research front.
Product range of the company includes: